NYSE:NBY NovaBay Pharmaceuticals (NBY) Stock Forecast, Price & News $0.65 0.00 (0.00%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$0.61▼$0.6550-Day Range N/A52-Week Range$0.61▼$12.64Volume145,257 shsAverage Volume291,488 shsMarket Capitalization$1.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaProfileChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media About NovaBay PharmaceuticalsNovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.Read More Receive NBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address NBY Stock News HeadlinesMay 27, 2023 | americanbankingnews.comNovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.comSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address NBY Company Calendar Today6/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:NBY CUSIPN/A CIK1389545 Webnovabay.com Phone(510) 899-8800Fax510-474-1577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($10.0751) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,610,000.00 Net Margins-89.72% Pretax Margin-89.72% Return on Equity-116.85% Return on Assets-65.13% Debt Debt-to-Equity RatioN/A Current Ratio2.24 Quick Ratio1.38 Sales & Book Value Annual Sales$14.40 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$2.17 per share Price / Book0.30Miscellaneous Outstanding Shares2,730,000Free Float2,694,000Market Cap$1.77 million OptionableNot Optionable Beta2.72 Key ExecutivesJustin M. HallPresident, CEO, Director & General CounselTommy LawChief Financial Officer, Treasurer & ControllerAudrey G. KuninDirector & Chief Product OfficerKey CompetitorsAthenexNASDAQ:ATNXCalithera BiosciencesNASDAQ:CALAStatera BiopharmaNASDAQ:STABSciSparcNASDAQ:SPRCContraFectNASDAQ:CFRXView All Competitors NBY Stock - Frequently Asked Questions How have NBY shares performed in 2023? NovaBay Pharmaceuticals' stock was trading at $0.6796 at the beginning of the year. Since then, NBY stock has decreased by 4.4% and is now trading at $0.6499. View the best growth stocks for 2023 here. What other stocks do shareholders of NovaBay Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include OpGen (OPGN) and Abbott Laboratories (ABT). What is NovaBay Pharmaceuticals' stock symbol? NovaBay Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "NBY." How do I buy shares of NovaBay Pharmaceuticals? Shares of NBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NovaBay Pharmaceuticals' stock price today? One share of NBY stock can currently be purchased for approximately $0.65. How much money does NovaBay Pharmaceuticals make? NovaBay Pharmaceuticals (NYSE:NBY) has a market capitalization of $1.77 million and generates $14.40 million in revenue each year. The company earns $-10,610,000.00 in net income (profit) each year or ($10.0751) on an earnings per share basis. How can I contact NovaBay Pharmaceuticals? NovaBay Pharmaceuticals' mailing address is 2000 POWELL STREET SUITE 1150, EMERYVILLE CA, 94608. The official website for the company is novabay.com. The company can be reached via phone at (510) 899-8800, via email at jcain@lhai.com, or via fax at 510-474-1577. This page (NYSE:NBY) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.